Clinical Trials
The following is a guide to learn more about a number of clinical trials that are taking place at pharmaceutical and medical device companies who are a part of HOPA’s Industry Relations Council (IRC).
To learn more about all active clinical trials, please visit clinicaltrials.gov.
Learn About Clinical Trials
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
- NSCLC – LUN-202 - A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients With Metastatic Non-Small-Cell Lung
- Solid Tumor Trial – NCT03645928 – A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN 144/LN-145/LN-145-S1) in Patients With Solid Tumors
- Cervical Cancer - NCT03108495 - A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients With Recurrent, Metastatic or Persistent Cervical Carcinoma
- CLL/SLL - NCT04155710 - A Phase 1/2 Study Evaluating the Safety and Efficacy of IOV-2001 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Iovance Clinical Trials
- Iovance Clinical Trials
